Also on its transparency wish list, set out in May 2017, is transparency of drug development costs and how prices are set. The industry – as expected – disagrees.

Introduction There are persistent gaps in access to affordable medicines. The WHO Model List of Essential Medicines (EML) includes medicines considered necessary for functional health systems.Methods ...